ResMed provides update on lawsuits in four countries

 - 
Friday, October 6, 2017

SAN DIEGO – ResMed says a German court has stayed infringement proceedings against Fisher & Paykel to allow ResMed to defend the validity of its patents in the European Patent Office. The stay follows an oral hearing in late September, during which the court concluded that F&P’s Simplus, Eson and Eson 2 infringe two ResMed European Patents, ResMed says. ResMed provided additional updates on its ongoing infringement proceedings against F&P: In the U.K., it says it is proceeding to trial to defend one of three of its patents that it says F&P has challenged there, and is agreeing to revoke two other patents; In Australia, it says after it presented evidence defending a key mask patent, F&P withdrew its validity challenge and now must pay its court costs; in New Zealand, it expects to go to trial in late 2018. “ResMed will continue to stand against those we believe have unlawfully violated our patents,” said David Pendarvis, ResMed global counsel and chief administrative officer. ResMed says it has more than 5,000 patents in its portfolio, representing three decades and millions of dollars of sustained investment in R&D.